Celldex Therapeutics | CLDX - Ebit

Stock Price
29.26
Daily Change
0.72 2.52%
Monthly
27.11%
Yearly
47.18%
Q1 Forecast
28.62

Celldex Therapeutics reported $-87.15M in EBIT for its fiscal quarter ending in December of 2025.





Ebit Change Date
AbbVie USD 5.81B 4.36B Dec/2025
Agenus USD 14.4M 19.26M Dec/2025
Amgen USD 3.96B 464M Dec/2025
Bristol-Myers Squibb USD 3.47B 567M Dec/2025
Celldex Therapeutics USD -87.15M 13.54M Dec/2025
Glaxosmithkline GBP 3.76B 1.69B Sep/2025
Nektar Therapeutics USD -34.34M 3.68M Sep/2024
Northwest Biotherapeutics USD -13.82M 248K Sep/2023
Pfizer USD 4.65B 71M Dec/2025
Rigel Pharmaceuticals USD 447K 1.52M Jun/2024
Roche Holding CHF 9.56B 2.1B Dec/2025